3 results
Approved WMOCompleted
The aim of this study is to investigate what proportion of HBeAg negative, inactive carriers of the hepatitis B virus with low (< 20,000 IU/mL) load will lose HBsAg when treated with nucleot(s)ide analogue/Peg-IFN combination therapy.
Approved WMOCompleted
The aim of this study is to assess the safety and efficacy of the new CaptivatorTM EMR kit.
Approved WMOPending
To evaluate our proposed SMS protocol in high-risk patients and compare it to a bi-annual US screening.